logo
  • Home
  • Patient Information
  • GTD Book
    • GTD – Front Page
    • GTD – Contents
    • GTD – Contributors
    • GTD – Preface
    • GTD – Foreword
    • GTD – C01 – Introduction
    • GTD – C02 – Genetics
    • GTD – C03 – Epidemiology
    • GTD – C04 – Pathology
    • GTD – C05 – hCG
    • GTD – C06 – Staging
    • GTD – C07 – FIGO Classification
    • GTD – C08 – Japan GTT
    • GTD – C09 – Presentation
    • GTD – C10 – Clinical Features
    • GTD – C11 – USA GTT
    • GTD – C12 – UK GTT
    • GTD – C13 – South America GTT
    • GTD – C14 – Europe GTT
    • GTD – C15 – Prophylactic Chemotherapy
    • GTD – C16 – Low Risk GTT
    • GTD – C17 – Metastatic GTT
    • GTD – C18 – Ultra High Risk GTT
    • GTD – C19 – CNS Disease
    • GTD – C20 – PSSTT and ETT
    • GTD – C21 – Surgery in GTT
    • GTD – C22 – Differences
    • GTD – C23 – Psychological
    • GTD – C24 – Late Toxicity
    • GTD – C25 – Future Prospects
  • Links
  • Contact
  • Members
    • Honorary Members
    • General Members

GESTATIONAL TROPHOBLASTIC DISEASE 4th EDITION (2015) – Chapter 19 – CNS Disease

<<< PREVIOUS PAGE
NEXT PAGE >>>

Download (PDF, 203KB)

Home » GTD Book » GTD – C19 – CNS Disease
© ISSTD 2016